Markets
News
Analysis
Tools
Learn
Stock
Score
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Inozyme Pharma Inc
expected to post a loss of 41 cents a share - Earnings Preview
Inozyme Pharma Inc INZY.OQ INZY.O is expected to show no change in quarterly revenue when it reports results on March 10 (estimated) for the period ending December 31 2024LSEG's mean analyst estimate for Inozyme Pharma Inc is for a loss of 41 cents per share. The current average analyst rating...
Reuters
Fri, Mar 7
Global Indemnity Group LLC
expected to post earnings of 77 cents a share - Earnings Preview
Global Indemnity Group LLC GBLI.N, GBLI.K is expected to show a rise in quarterly revenue when it reports results on March 11 for the period ending December 31 2024The Bala Cynwyd Pennsylvania-based company is expected to report a 4.3% increase in revenue to $114 million from $109.26 million a yea...
Reuters
Fri, Mar 7
Achieve Life Sciences Inc
expected to post a loss of 32 cents a share - Earnings Preview
Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to show no change in quarterly revenue when it reports results on March 11 for the period ending December 31 2024LSEG's mean analyst estimate for Achieve Life Sciences Inc is for a loss of 32 cents per share. The current average analyst rati...
Reuters
Fri, Mar 7
Kalvista Pharmaceuticals Inc
expected to post a loss of 87 cents a share - Earnings Preview
Kalvista Pharmaceuticals Inc KALV.OQ KALV.O is expected to show no change in quarterly revenue when it reports results on March 10 (estimated) for the period ending January 31 2025LSEG's mean analyst estimate for Kalvista Pharmaceuticals Inc is for a loss of 87 cents per share. The current ave...
Reuters
Fri, Mar 7
Endeavour Silver Corp
expected to post a loss of 1 cent a share - Earnings Preview
Endeavour Silver Corp EDR.TO is expected to show a fall in quarterly revenue when it reports results on March 11 for the period ending December 31 2024The Vancouver British Columbia-based company is expected to report a 2.9% decrease in revenue to $49.022 million from $50.5 million a year ago, ac...
Reuters
Fri, Mar 7
Ciena Corp
expected to post earnings of 41 cents a share - Earnings Preview
Ciena Corp CIEN.N, CIEN.K is expected to show a rise in quarterly revenue when it reports results on March 11 for the period ending January 31 2025The Hanover Maryland Maryland-based company is expected to report a 1.4% increase in revenue to $1.052 billion from $1.04 billion a year ago, according...
Reuters
Fri, Mar 7
Solid Biosciences Inc
expected to post a loss of 60 cents a share - Earnings Preview
Solid Biosciences Inc SLDB.OQ SLDB.O is expected to show no change in quarterly revenue when it reports results on May 13 (estimated) for the period ending March 31 2025LSEG's mean analyst estimate for Solid Biosciences Inc is for a loss of 60 cents per share. The current average analyst ratin...
Reuters
Fri, Mar 7
Legend Biotech Corp
expected to post a loss of 33 cents a share - Earnings Preview
Legend Biotech Corp LEGN.OQ LEGN.O is expected to show a rise in quarterly revenue when it reports results on March 11 for the period ending December 31 2024The Somerset New Jersey-based company is expected to report a 125.2% increase in revenue to $178.934 million from $79.46 million a year ago, ...
Reuters
Fri, Mar 7
CorMedix Inc
expected to post earnings of 13 cents a share - Earnings Preview
CorMedix Inc CRMD.OQ CRMD.O is expected to show a rise in quarterly revenue when it reports results on March 10 (estimated) for the period ending December 31 2024The Berkeley Heights New Jersey-based company is expected to report revenue of $25.414 million, according to the mean estimate from 4 an...
Reuters
Fri, Mar 7
Acurx Pharmaceuticals Announces $1.1 Million Registered Direct Offering
March 7 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O:ACURX PHARMACEUTICALS, INC. ANNOUNCES $1.1 MILLION REGISTERED DIRECT OFFERING
Reuters
Fri, Mar 7
Wolfspeed To Reduce Headcount By Approximately 180 Employees
March 7 (Reuters) - Wolfspeed Inc WOLF.N:WOLFSPEED INC - TO REDUCE HEADCOUNT BY APPROXIMATELY 180 EMPLOYEESWOLFSPEED INC: IN Q3 OF FY2025, EXPECTS TO TAKE A ONE-TIME CHARGE RELATING TO A LITIGATION SETTLEMENTWOLFSPEED INC: HAS RECEIVED ITS CONDITIONAL CERTIFICATE OF OCCUPANCY FOR SILER CITY MATERIAL...
Reuters
Fri, Mar 7
Hub International Acquires Retirement And Private Wealth Books Of Business In Tennessee
March 7 (Reuters) - HUB International Ltd [RIC:RIC:HBINT.UL]:HUB INTERNATIONAL ACQUIRES RETIREMENT AND PRIVATE WEALTH BOOKS OF BUSINESS IN TENNESSEEFurther company coverage: HBINT.UL
Reuters
Fri, Mar 7
RumbleOn Inc
expected to post a loss of 31 cents a share - Earnings Preview
RumbleOn Inc RMBL.OQ RMBL.O is expected to show a fall in quarterly revenue when it reports results on March 12 for the period ending December 31 2024The Irving Texas-based company is expected to report a 10.5% decrease in revenue to $278.433 million from $311.1 million a year ago, according to th...
Reuters
Fri, Mar 7
Nuwellis Inc
expected to post a loss of 43 cents a share - Earnings Preview
Nuwellis Inc NUWE.OQ NUWE.O is expected to show a fall in quarterly revenue when it reports results on March 11 for the period ending December 31 2024The Eden Prairie Minnesota-based company is expected to report a 3.5% decrease in revenue to $2.462 million from $2.55 million a year ago, according...
Reuters
Fri, Mar 7
Nasdaq President Tal Cohen Says Nasdaq Will Enable 24-Hour Trading Anticipate Timeline Being In The Second Half Of 2026 - Linkedin Post
March 7 (Reuters) - NASDAQ PRESIDENT TAL COHEN SAYS NASDAQ WILL ENABLE 24-HOUR TRADING; ANTICIPATE TIMELINE BEING IN THE SECOND HALF OF 2026 - LINKEDIN POSTNASDAQ PRESIDENT COHEN : NASDAQ HAS BEGUN ENGAGING WITH REGULATORS TO ENABLE 24-HOUR TRADING FIVE DAYS A WEEK ON THE NASDAQ STOCK MARKETSource t...
Reuters
Fri, Mar 7
Biocon Biologics Announces Positive Results From Phase 3 Study Of Yesintek
March 7 (Reuters) - Biocon Ltd BION.NS:BIOCON BIOLOGICS ANNOUNCES POSITIVE RESULTS FROM PHASE 3 STUDY OF YESINTEK™ BIOSIMILAR TO USTEKINUMAB FOR CHRONIC PLAQUE PSORIASISBIOCON LTD - YESINTEK DEMONSTRATES EQUIVALENT EFFICACY AND SAFETY TO STELARA
Reuters
Fri, Mar 7
Holley Inc
expected to post earnings of 2 cents a share - Earnings Preview
Holley Inc HLLY.N, HLLY.K is expected to show a fall in quarterly revenue when it reports results on March 11 for the period ending December 31 2024The Bowling Green Kentucky-based company is expected to report a 11.6% decrease in revenue to $137.602 million from $155.71 million a year ago, accord...
Reuters
Fri, Mar 7
Cimpress PLC Estimated Annual Impact Of Tariffs Less Than $10 Million
March 7 (Reuters) - Cimpress PLC CMPR.O:CIMPRESS PLC - ESTIMATED ANNUAL IMPACT OF TARIFFS LESS THAN $10 MILLIONSource text: [ID:n0001262976-25-000028]
Reuters
Fri, Mar 7
Clene Inc.
expected to post a loss of 95 cents a share - Earnings Preview
Clene Inc. CLNN.OQ CLNN.O is expected to show a fall in quarterly revenue when it reports results on March 11 (estimated) for the period ending December 31 2024The Salt Lake City Utah-based company is expected to report a 23.5% decrease in revenue to $130 thousand from $170 thousand a year ago, ac...
Reuters
Fri, Mar 7
Clear Channel Outdoor Appoints Eric Hamme As Chicago Market President
March 7 (Reuters) - Clear Channel Outdoor Holdings Inc CCO.N:CLEAR CHANNEL OUTDOOR APPOINTS ERIC HAMME AS CHICAGO MARKET PRESIDENT
Reuters
Fri, Mar 7
1
...
3667
3668
3669
3669
/
5111
3670
3671
...
5111
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up